Cardiometabolic Syndrome: Clinical Trials

56 trials for Cardiometabolic Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 13 recruiting, 13 unknown, 3 not yet recruiting. 40 Not applicable, 3 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable40Completed 20, Recruiting 9, Unknown 5, Active not recruiting 2, Not yet recruiting 2, Enrolling by invitation 1, Terminated 1
Phase 23Completed 1, Recruiting 1, Unknown 1
Phase 31Not yet recruiting 1
Phase 41Recruiting 1

Follow Cardiometabolic Syndrome: new trials by email Literature Review of Cardiometabolic Syndrome trials Research Report on Cardiometabolic Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk
Bupropion 150 mg, Lyophilized powder from edible mushrooms, Lifestyle Management - Cardiometabolic Syndrome, Obesity and Cardiovascular Risk
Phase 3Not yet recruitingUppsala University2502026-10-302026-09-08
Effects of Berberine on Cardiometabolic Outcomes
Berberine, Placebo - Cardiometabolic Syndrome
Not applicableNot yet recruitingUniversity of Central Lancashire402026-07-012026-04-21
FEAST Perinatal Support Program Intervention
FEAST Perinatal Support Program - Diet, Healthy, Obesity
Not applicableRecruitingUniversity of Southern California402026-02-012026-02-02
PDE3B in Metabolic Regulation
Type 2 Diabetes, Cardiometabolic Syndrome
Enrolling by invitationCambridge University Hospitals NHS Foundation Trust402025-09-012025-11-24
LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL - Drug Interactions, Primary Prevention
Phase 4RecruitingUniversity of California, San Diego1002025-04-022026-07-13
Effects of Green Tea on Cardiometabolic Outcomes
Green tea, Placebo - Cardiometabolic Syndrome
Not applicableNot yet recruitingUniversity of Central Lancashire402025-04-012025-03-27
Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body
Hyperpolarized 13C-pyruvate - Heart Failure, Cardiometabolic Syndrome
Phase 2RecruitingNational Heart Centre Singapore2002024-10-172024-12-06
Time Restricted Eating (TRE) and High-Intensity Interval Training (HIIT) to Improve Health in Patients With Metabolic Syndrome (METS)
High-Intensity Interval Training, Experimental: Time-Restricted Eating - Metabolic Syndrome, Exercise
Not applicableCompletedUniversity of Castilla-La Mancha2002024-09-012026-05-08
Peau o le Vasa: Analysis of the Efficacy and Feasibility of the PILI Lifestyle Program (PLP) + Social Determinants of Health (SDOH) Intervention and Adaptation of SDOH Measures Pilot Study
Partnership for Improving Lifestyle Intervention (PILI) Lifestyle Program + Social Determinants of Health (SDOH) Component - Weight Loss Trial, Cardiometabolic Syndrome
Not applicableCompletedUniversity of Hawaii2422024-09-012025-10-27
The Role of Ectopic Fat and Heart Attack Risk in HIV
Non-interventional - Cardiometabolic Syndrome, Hiv
RecruitingUniversity of Liverpool1002024-08-012026-02-19
The Mom and Infant Outcomes (MOMI) Study
MOMI PODS, Enhanced Usual Care (EUC) - Postpartum Depression, Postpartum Anxiety
Not applicableRecruitingOhio State University3842024-06-272026-05-14
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
Chardonnay Marc - Cardiovascular Diseases, Adiposity
Not applicableRecruitingUniversity of California, Davis52024-06-012026-08-07
Interval Training and Cardio-metabolic Health in Overweight/Obese Girls
MIIT, MIIT + HIIT, Control group - Exercise Overtraining, Enjoyment
Not applicableUnknownAssociation Tunisienne d'Etude & de Recherche sur l'Athérosclérose452024-05-202024-08-06
iPSC Biobank of Biomarkers Diversity in Cardiovascular Disease
Cardiovascular Diseases, Arrythmia
RecruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2002024-05-012024-05-29
Spinal Cord Injury Model Systems (SCIMS) - Education Module
PVA Consumer Guide, WebMD - Spinal Cord Injuries, Obesity
Not applicableRecruitingUniversity of Miami2502024-03-052026-09-30
Effects of Quercetin on Cardiometabolic Outcomes
Quercetin, Placebo - Cardiometabolic Syndrome
Not applicableRecruitingUniversity of Central Lancashire402024-03-012026-09-10
Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico
Mindfulness-based Stress reduction program: Virtual, Home exercises - Psychological Distress, Cardiometabolic Syndrome
Not applicableCompletedEmory University242024-02-172025-06-27
RE-inventing Strategies for Healthy Ageing; Recommendations and Tools
Complex lifestyle intervention, Physical activity monitoring and recommendations - Lifestyle, Healthy, Muscle Weakness
Not applicableActive not recruitingUniversity of Tromso1192024-01-152026-04-29
Metabolic Flexibility and Autonomic Control After Muscle Power vs Metabolic Power Training in Postmenopausal Oncological Women: the POWER Health Study
HIIT program (8 weeks), MPI program (8 weeks) - Breast Cancer Female, Cardiometabolic Syndrome
Not applicableRecruitingUniversity of Valencia562024-01-012024-04-04
FINRISK 2002 Re-examination
Questionnaire and fecal sampling, Health examination - Cardiometabolic Syndrome, Cardiovascular Diseases
CompletedUniversity of Turku25002023-11-132024-12-09

Showing 20 of 56. Sign in to see all of them.

Narrower conditions

Metabolic Syndrome (56)  ·  Obesity (21)  ·  Cardiovascular Diseases (9)  ·  Motor Activity (7)  ·  Hypertension (6)  ·  Overweight (6)  ·  Intermittent Fasting (5)  ·  Weight Loss (5)  ·  Diabetes Mellitus, Type 2 (4)  ·  Inflammation (4)  ·  Obesity, Abdominal (4)  ·  Dyslipidemias (3)  ·  Heart Failure (3)  ·  Prediabetic State (3)  ·  Body Weight (2)

Broader conditions

Hyperinsulinism (56)  ·  Nutritional and Metabolic Diseases (56)  ·  Glucose Metabolism Disorders (55)  ·  Metabolic Diseases (55)  ·  Insulin Resistance (54)  ·  Pathological Conditions, Signs and Symptoms (30)  ·  Signs and Symptoms (27)  ·  Nutrition Disorders (26)  ·  Overnutrition (26)  ·  Body Weight (25)  ·  Overweight (20)  ·  Behavior (13)  ·  Vascular Diseases (9)  ·  Pathologic Processes (8)  ·  Endocrine System Diseases (7)

Interventions

Control Groups (2)  ·  Exercise (2)  ·  ALN-PCS (1)  ·  Berberine (1)  ·  Bupropion (1)  ·  Cardiac Rehabilitation (1)  ·  Diet (1)  ·  Diet, Carbohydrate-Restricted (1)  ·  Diet, Fat-Restricted (1)  ·  Diet, Mediterranean (1)  ·  Diet, Vegan (1)  ·  Elements (1)  ·  Health Records, Personal (1)  ·  High-Intensity Interval Training (1)  ·  Laparoscopy (1)

Sponsors

University of Central Lancashire (4)  ·  Lindenwood University (2)  ·  Ohio State University (2)  ·  Qure Healthcare, LLC (2)  ·  Universidad de Granada (2)  ·  Abcentra (1)  ·  Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Columbia University (1)  ·  Emory University (1)  ·  Faculty Hospital Kralovske Vinohrady (1)  ·  Florida State University (1)  ·  Fu Jen Catholic University (1)  ·  Göteborg University (1)  ·  Jonathan Sinclair (1)

Countries

United States (20)  ·  United Kingdom (7)  ·  Spain (5)  ·  Canada (3)  ·  Indonesia (2)  ·  Norway (2)  ·  Singapore (2)  ·  Sweden (2)  ·  Brazil (1)  ·  China (1)  ·  Czechia (1)  ·  Finland (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Poland (1)

Top investigators

Chad M Kerksick, PhD (2)  ·  Jonatan R. Ruiz, PhD (2)  ·  Andrea Lopez-Cepero, PhD (1)  ·  Antoinette Birs, MD (1)  ·  Christophe Matthys, PhD (1)  ·  Cristina Blasco Lafarga, Tenured Professor (1)  ·  Dicky L Tahapary (1)  ·  Eric D Adler, MD (1)  ·  Gary Farkas, PhD (1)  ·  Irena D Aldhoon Hainerova, MD PhD (1)  ·  Jan Eriksson, MD, PhD (1)  ·  Joel Neutel, MD (1)

Results publications

PMID 16046715, PMID 19442301, PMID 21092228, PMID 25136585, PMID 25593845, PMID 26131326, PMID 28188334, PMID 29197155, PMID 29697773, PMID 30806875, PMID 32156010, PMID 32819304, PMID 33848440, PMID 34919906, PMID 35464093, PMID 35907092, PMID 35977864, PMID 35989865, PMID 36270544, PMID 37061690, PMID 38267239, PMID 38471681, PMID 38510748, PMID 38523341, PMID 39358106, PMID 39551766, PMID 39696111, PMID 39775037, PMID 39854690, PMID 40254301, PMID 40533200, PMID 40560588, PMID 40732902, PMID 40760353, PMID 40996070, PMID 41161844, PMID 41619951, PMID 41820730, PMID 42302513, PMID 42413768

NIH funding

2023 (1), K12AR084234 (1), OT2HL158287 (1), P30AG028740 (1), P50MD017344 (1), R35HL155670 (1)